As of 2024-12-14, the Relative Valuation of Devyser Diagnostics AB (DVYSR.ST) is (75.91) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 122.00 SEK, the upside of Devyser Diagnostics AB based on Relative Valuation is -162.2%.
The range of the Relative Valuation is (67.66) - (80.68) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 18.6x | 15.5x |
| Forward P/E multiples | 15.6x - 23.4x | 19.5x |
| Fair Price | (67.66) - (80.68) | (75.91) |
| Upside | -155.5% - -166.1% | -162.2% |
| Date | P/E |
| 2024-12-06 | -28.59 |
| 2024-12-05 | -28.47 |
| 2024-12-04 | -28.36 |
| 2024-12-03 | -28.70 |
| 2024-12-02 | -29.74 |
| 2024-11-29 | -29.97 |
| 2024-11-28 | -30.43 |
| 2024-11-27 | -30.55 |
| 2024-11-26 | -31.35 |
| 2024-11-25 | -31.01 |
| 2024-11-22 | -29.74 |
| 2024-11-21 | -30.32 |
| 2024-11-20 | -30.66 |
| 2024-11-19 | -30.43 |
| 2024-11-18 | -30.43 |
| 2024-11-15 | -30.43 |
| 2024-11-14 | -31.35 |
| 2024-11-13 | -30.66 |
| 2024-11-12 | -31.82 |
| 2024-11-11 | -32.05 |
| 2024-11-08 | -31.35 |
| 2024-11-07 | -31.70 |
| 2024-11-06 | -31.12 |
| 2024-11-05 | -31.01 |
| 2024-11-04 | -31.01 |
| 2024-11-01 | -31.93 |
| 2024-10-31 | -29.51 |
| 2024-10-30 | -30.09 |
| 2024-10-29 | -30.55 |
| 2024-10-28 | -29.28 |
| 2024-10-25 | -29.40 |
| 2024-10-24 | -29.51 |
| 2024-10-23 | -30.20 |
| 2024-10-22 | -29.74 |
| 2024-10-21 | -29.63 |
| 2024-10-18 | -30.09 |
| 2024-10-17 | -29.86 |
| 2024-10-16 | -29.63 |
| 2024-10-15 | -29.74 |
| 2024-10-14 | -30.20 |
| 2024-10-11 | -30.55 |
| 2024-10-10 | -30.32 |
| 2024-10-09 | -31.12 |
| 2024-10-08 | -31.35 |
| 2024-10-07 | -30.20 |
| 2024-10-04 | -29.16 |
| 2024-10-03 | -29.28 |
| 2024-10-02 | -29.28 |
| 2024-10-01 | -29.63 |
| 2024-09-30 | -29.28 |